HOME › DRUGS › FERUMOXYTOL
ACTIVE SUBSTANCE / INN

FERUMOXYTOL

Brand name(s): FERAHEME, Feraheme, FERABRIGHT, FERUMOXYTOL, Rienso
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
WITHDRAWN
ANDA206604
Anemia;Kidney Failure, Chronic
ACTIVE SUBSTANCE
Ferumoxytol
REGULATORS
FDA · EMA
SPONSORS / MAH
SANDOZ, Takeda Pharma A/S, COVIS
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
FERUMOXYTOLANDA206604SANDOZPrescription
FERABRIGHTNDA219868COVISPrescription
FERAHEMENDA022180COVISPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FerahemeCovis Pharma Europe B.V.Application withdrawnAnemia, Iron-Deficiency
RiensoTakeda Pharma A/SWithdrawn15/06/2012Anemia;Kidney Failure, Chronic

FULL INTELLIGENCE ON FERUMOXYTOL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →